
Serelam0.25 mg
General Pharmaceuticals Ltd.
Alprazolam is a short-acting benzodiazepine indicated for the following conditions: Established / FDA-approved uses Generalized Anxiety Disorder (GAD): Short-term relief of symptoms of anxiety and more.
Alprazolam is a short-acting benzodiazepine indicated for the following conditions:
Alprazolam is not indicated for the routine treatment of stress or anxiety of everyday life, and is generally not recommended as a first-line or long-term treatment given its potential for dependence.
| Population | Dose |
|---|---|
| Adults | Initial 0.25-0.5 mg three times daily; may be titrated based on response and tolerability, generally up to a maximum of 4 mg/day in divided doses. |
| Elderly or debilitated patients | Initial 0.25 mg two to three times daily, increased gradually and cautiously if needed. |
| Population | Dose |
|---|---|
| Adults | Initial 0.5 mg three times daily; dose may be increased in increments of no more than 1 mg every 3-4 days as needed and tolerated. Total daily doses of up to 10 mg have been used in clinical trials, but higher doses substantially increase sedation and dependence risk. |
Use a lower starting dose and titrate cautiously; clearance of Alprazolam is reduced in liver disease.
Alprazolam must never be stopped abruptly after regular use. Discontinuation must be achieved by a gradual dose taper under medical supervision (see Precautions and Warnings) to reduce the risk of withdrawal symptoms, including seizures.
Alprazolam is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.